Intracavitary Doxorubicin Hydrochloride Treatment for Carcinoma in situ of the Urinary Bladder
- 1 January 1981
- journal article
- Published by Elsevier in European Urology
- Vol. 7 (2) , 68-72
- https://doi.org/10.1159/000473182
Abstract
In two subsequent, non-randomized groups of 9 patients with carcinoma in situ doxorubicin hydrochloride was applied intravesically. The dosage used was 40 and 80 mg. Tumour remission was obtained in 6 patients per group. The tumour grade might be of prognostic value. Cold cup random biopsies are warranted in the follow-up.Keywords
This publication has 0 references indexed in Scilit: